<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Key_Pomalidomide_Procedures_Simplified</id>
		<title>Key Pomalidomide Procedures Simplified - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Key_Pomalidomide_Procedures_Simplified"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Key_Pomalidomide_Procedures_Simplified&amp;action=history"/>
		<updated>2026-06-15T10:30:56Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Key_Pomalidomide_Procedures_Simplified&amp;diff=123386&amp;oldid=prev</id>
		<title>Net64tax: Створена сторінка: Thus, a total of 26 case�Ccontrol studies[10-16, 29, 31-48] met inclusion criteria and were included in the current meta-analysis (Fig.?1). Characteristics an...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Key_Pomalidomide_Procedures_Simplified&amp;diff=123386&amp;oldid=prev"/>
				<updated>2016-12-22T01:24:10Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Thus, a total of 26 case�Ccontrol studies[10-16, 29, 31-48] met inclusion criteria and were included in the current meta-analysis (Fig.?1). Characteristics an...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Thus, a total of 26 case�Ccontrol studies[10-16, 29, 31-48] met inclusion criteria and were included in the current meta-analysis (Fig.?1). Characteristics and genotype distribution of each case�Ccontrol study are shown in Table?1. Figures?2-5 show the summary of meta-analysis for GSTM1and GSTT1 polymorphisms with asthma risk. When all groups were pooled, the random-effects model was conducted if the heterogeneity was significant; otherwise the fixed-effects [http://www.selleckchem.com/products/nutlin-3a.html Nutlin 3a] model was conducted. Twenty-six studies with a total of 3680 cases and 4350 controls were included in the GSTM1 polymorphism meta-analysis. For the GSTT1 polymorphism, 22 studies with a total of 3167 cases and 3209 controls were included. The pooled results showed a significant association for both the GSTM1 polymorphism (null vs present, OR?=?1.452; 95% CI: 1.192�C1.770; P?[http://www.selleckchem.com/products/Pomalidomide(CC-4047).html selleck products] 95% CI: 0.866�C7.479; P?=?0.090; I2?=?92.2%). Because Russia stretches across Europe and Asia, it was considered a distinct ethnic group in the current meta-analysis. Based on subgroup analysis by ethnicity, for GSTM1, a significant association was found for Europe (OR?=?1.303; 95% CI: 1.018�C1.667; P?=?0.036; I2?=?36.1%), Africa (OR?=?2.175; 95% CI: 1.560�C3.031; P?[https://en.wikipedia.org/wiki/Oxymatrine Oxymatrine] association in Asia (OR?=?1.364; 95% CI: 0.981�C1.897; P?=?0.065; I2?=?83.2%) and Russia (OR?=?1.467; 95% CI: 0.846�C2.544; P?=?0.172; I2?=?73.4%). For GSTT1, significantly increased risk was found for Asia (OR?=?2.105; 95% CI: 1.101�C4.025; P?=?0.024; I2?=?91.9%) and Russia (OR?=?2.747; 95% CI: 1.071�C7.046; P?=?0.035; I2?=?86.4%), but not Europe (OR?=?1.381; 95% CI: 0.910�C2.096; P?=?0.130; I2?=?65.6%), Africa (OR?=?1.240; 95% CI: 0.887�C1.734; P?=?0.208; I2?=?0.0%) or Latin America (OR?=?0.920; 95% CI: 0.477�C1.775; P?=?0.804; I2?=?0.0%).&lt;/div&gt;</summary>
		<author><name>Net64tax</name></author>	</entry>

	</feed>